Mechanism of SHP2 activation by bis-Tyr-phosphorylated Gab1
Lisa Machner, Alaa ShaikhqasemiD, Tobias Gruber, Farzad HamdiiD, Constanze Breithaupt, Judith Kniest, Felix Wiebe, Marc LewitzkyiD, C. ParthieriD, Fotis L. KyrilisiD, Jochen BalbachiD, Panagiotis L. KastritisiD, Stephan M. FelleriD, Milton T. StubbsiD
Abstract
The non-receptor tyrosine phosphatase SHP2 (PTPN11) is a regulator of diverse cellular functions including mitogenic activation and cell migration. SHP2 consists of two tandem SH2 domains followed by the catalytic domain, and is autoinhibited by the N-terminal SH2 domain that blocks access to the active site. Mutations that influence auto-inhibition have been implicated in cancer and other diseases, and allosteric inhibitors have been developed that stabilise the inactive state. The mechanism of SHP2 activation remains unclear, however. Here, we show that the intrinsically disordered bis-phosphorylated SHP2-activating peptide pY627pY659-Gab1 binds to both SH2 domains, undergoing a partial disorder-to-order transition in the process. In addition to eliciting changes in SH2 domain dynamics, the peptide reorganises their relative orientations to provide a new SH2-SH2 interface. Our data suggest an active conformation for SHP2 that is also applicable to the hematopoietic cell-specific SHP1 (PTPN6), shedding light on the activation mechanism of both enzymes and paving the way for the development of novel compounds that modulate SHP2 activity.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 1.79
- Field percentile
- top 14%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An allosteric interaction controls the activation mechanism of SHP2 tyrosine phosphatase
M. Anselmi, J. S. Hub·Scientific ReportsPeer-reviewed·Oct 28, 2020
- Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase
M. Anselmi, P. Calligari, … L. Stella·bioRxiv·Mar 27, 2020
- Phosphatase SHP2 pathogenic mutations enhance activity by altering conformational sampling
Andrew Glaser, R.A.P. Padua, … Dorothee Kern·Proceedings of the National Academy of SciencesPeer-reviewed·Jan 13, 2026
- Atomistic ensemble of active SHP2 phosphatase
M. Anselmi, J. S. Hub·bioRxiv·May 4, 2023
- Grb2 binding induces phosphorylation-independent activation of Shp2
C.-C. Lin, L. Wieteska, … J. E. Ladbury·bioRxiv·Nov 29, 2019
- The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain
A. E. van Vlimmeren, R. Voleti, … N. H. Shah·bioRxiv·Jul 10, 2023